Аллергические болезни: диагностика и лечение - Паттерсон Р.
ISBN 5-9231-0011-8
Скачать (прямая ссылка):
65. Drouin M.A. Hj antihistamines: perspective of the use of the conventional and new agents // Ann. Allergy. - 1985. - Vol. 55. - P. 747.
66. Connell J.T. et al. Antihistamines: findings in clinical trials relevant to therapeutics // Ann. J.Rhin. - 1987.-Vol. 1.-P.3.
67. Wong L. et al. Pharmacologic prophylaxis of allergic rhinitis: relative efficacy of hydroxyzine and chlorpheniramine // J. Allergy Clin. Immunol. - 1981. - Vol. 67. - P. 223.
68. SchaafL. et al. Suppression of seasonal allergic rhinitis symptoms with daily hydroxyzine // Ibid. - 1979. - Vol. 3. - P. 129.
90
69. Empey D.W. et al. A double-blind crossover trial of pseudoephedrine and triprolidine: alone and in combination for the treatment of allergic rhinitis // Ann. Alleigy. - 1975. - Vol. 34. - P. 41.
70. Diamond L. et al. An evaluation of triprolidine and pseudoephedrine in the treatment of allergic rhinitis // Ibid. - 1981. - Vol. 47. - P. 87.
71. Guill M.E. et al. Multicenter, double blind, placebo-controlled trial of terfenadine suspension in the treatment of fall-allergic rhinitis in children // J. Allergy Clin. Immunol. - 1986. - Vol. 78. -P. 4.
72. Sooknundun M. et al. Treatment of allergic rhinitis with a new long-acting H,-receptor antagonist: astemizole // Ann. Allergy. - 1987. - Vol. 58. - P. 78.
73. Kreutner W. et al. Antiallergic activity of loratadine, a nonsedating antihistamine 11 Allergy. -
1987. - Vol. 42. - P. 57.
74. Howarth P.H., Holgate S.T. Comparative trial of two nonsedative Hj antihistamines, terfenadine and astemizole, for hay fever 11 Thorax. - 1984. - Vol. 39. - P. 668.
75. Juniper E.F. et al. Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis // J. Allergy Clin. Immunol. - 1988. -Vol. 82. - P. 670.
76. Boland N. A double-blind study of astemizole and terfenadine in the treatment of perennial rhinitis // Ann. Allergy. - 1988. - Vol. 61. - P. 18.
77. Dockhorn R.J. et al. Safety and efficacy of loratadine (Sch-29851): a new nonsedating antihistamine in seasonal allergic rhinitis // Ibid. - 1987. - Vol. 58. - P. 407.
78. Bruttman G. et al. Evaluation of the efficacy and safety of loratadine in perennial allelic rhinitis // J. Allergy Clin. Immunol. - 1989. - Vol. 83. - P. 411.
79. Bruno G. et al. Prolonged treatment with acrivastine for seasonal allergic rhinitis 11 J. Int. Med. Res. - 1989. - Vol. 17. - P. 41B.
80. Gervais P. et al. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis // Ibid. - P. 47B.
81. Grossman J. et al. Cetirizine vs. Terfenadine in the Treatment of Seasonal Allergic Rhinitis. -Kansas City: Marion Merrell Dow, Inc.
82. Skassa-Brociek W. et al. Double-blind placebo-controlled study of loratadine mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis // J. Allergy Clin. Immunol. -
1988.-Vol. 81.-P. 725.
83. Gutkowski A. et al. Comparison of the efficacy and safety of loratadine, terfenadine and placebo in the treatment of seasonal allergic rhinitis // Ibid. - P. 902.
84. Zuber P., Pecoud A. Effect of levocabastine, a new H,-antagonist, in a conjunctival provocation test with allergens // J. Allergy Clin. Immunol. - 1988. - Vol. 82. - P. 590.
85. Simons F.E.R. et al. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis // J. Pediatr. - 1984. - Vol. 104. - P. 123.
86. Wanderer A.A. et al. Primary acquired cold urticaria: double blind study of treatment with crypro-heptadine, chlorpheniramine and placebo // Arch. Dermatol. - 1977. - Vol. 113. - P. 1375.
87. Berstein I.L., Bernstein D.L. Efficacy and safety of astemizole, a long-acting and nonsedating Hj-antagonist for the treatment of chronic idiopathic urticaria // J. Allergy Clin. Immunol. - 1986. -Vol. 77. - P. 37.
88. Fox R.W. et al. The treatment of mild to severe chronic idiopathic urticaria with astemizole: double-blind and open trials // Ibid. - Vol. 78. - P. 1159.
89. Sly M.R. et al. Position statement: the use of antihistamines in patients with asthma // Ibid. -
1988.-Vol. 82.-P. 481.
90. Pierson W.E., Virant F.S. Antihistamines in asthma // Ann. Allergy. - 1989. - Vol. 63. - P. 601.
91. Rafferty P. The European experience with antihistamines in asthma // Ibid. - P. 389.
92. Rafferty P., Holgate S.T. Histamine and its antagonists in asthma // J. Allergy Clin. Immunol. -
1989.-Vol. 84.-P. 144.
91
93. Oilier S. et al. The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing // Ibid. - 1986. - Vol. 78. - P. 358.
94. Rafferty P. et al. The in vivo potency and selectivity of azelastine as an H, histamine-receptor antagonist in human airways and skin 11 Ibid. - 1988. - Vol. 82. - P. 1113.
95. Cantekin E.L. et al. Lack of efficacy of a decongestant-antihistamine combination of otitis media with effusion in children // N. Engl. J. Med. - 1987. - Vol. 316. - P. 432.
